Viking Fund Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
FWIA
DLA
AAMU
ORIO
CNB
UBP
Viking Fund Management's BMY Position: Q2 2026 in Review
Viking Fund Management increased its Bristol-Myers Squibb (BMY) stake by 19% in Q2 2026, buying an estimated $4.02M and bringing the position to 443,000 shares worth $25.5M. The position accounts for 2.29% of the portfolio, ranked #7.
Viking Fund Management first reported a position in BMY in Q3 2019 and has held it in 21 quarters since. 500 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Viking Fund Management held 443,000 shares of Bristol-Myers Squibb worth $25.5M as of Q2 2026.
- Viking Fund Management bought 70,000 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.02M.
- Bristol-Myers Squibb made up 2.29% of Viking Fund Management's portfolio in Q2 2026, its #7 holding.
- Viking Fund Management first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 21 quarters since.
- 500 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Viking Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.